| 发明名称 |
Treatment of Diabetes |
| 摘要 |
Glycated hemoglobin (HbA1c) levels and other characteristics of diabetes are reduced by administering to a human subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α. |
| 申请公布号 |
US2017081403(A1) |
申请公布日期 |
2017.03.23 |
| 申请号 |
US201615364597 |
申请日期 |
2016.11.30 |
| 申请人 |
XBiotech, Inc. |
发明人 |
Simard John |
| 分类号 |
C07K16/24;A61K39/395;A61K9/00 |
主分类号 |
C07K16/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating diabetes in a human subject, the method comprising the step of repeatedly administering to the subject a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an anti-interleukin-1alpha (IL-1α) antibody until the subject's beta cell function is improved. |
| 地址 |
Vancouver CA |
